Amar Gajjar Selected Research

Hormones (Hormone)

2/2015	Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study.
3/2008	Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amar Gajjar Research Topics

Disease

110	Neoplasms (Cancer) 04/2024 - 01/2002
74	Medulloblastoma 04/2024 - 08/2002
55	Brain Neoplasms (Brain Tumor) 12/2023 - 08/2002
36	Glioma (Gliomas) 01/2024 - 07/2002
20	Ependymoma 10/2019 - 07/2009
15	Diffuse Intrinsic Pontine Glioma 01/2023 - 11/2010
13	Primitive Neuroectodermal Tumors (PNET) 10/2022 - 08/2004
9	Central Nervous System Neoplasms 01/2023 - 12/2003
8	Hearing Loss (Hearing Impairment) 01/2020 - 02/2011
7	Diarrhea 01/2021 - 07/2002
6	Astrocytoma (Pilocytic Astrocytoma) 01/2023 - 02/2007
6	Disease Progression 01/2016 - 01/2005
6	Rhabdoid Tumor (Rhabdoid Tumors) 06/2015 - 03/2005
6	Ototoxicity 03/2015 - 10/2005
6	Glioblastoma (Glioblastoma Multiforme) 04/2014 - 01/2004
5	Typical Teratoid Rhabdoid Tumor 01/2023 - 11/2006
4	Hypothyroidism 01/2023 - 03/2008
4	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 10/2022 - 02/2006
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022 - 07/2009
4	Choroid Plexus Carcinoma 01/2021 - 07/2009
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2008 - 07/2002
3	Cognitive Dysfunction 01/2023 - 10/2006
3	Precocious Puberty 01/2023 - 03/2016
3	Pinealoma (Pineoblastoma) 01/2020 - 01/2020
3	Hydrocephalus (Hydrocephaly) 12/2019 - 07/2004
3	Exanthema (Rash) 10/2019 - 01/2009
3	Neutropenia 06/2007 - 01/2005
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2023 - 01/2023
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2023 - 10/2020
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023 - 01/2020
2	Neuroblastoma 10/2022 - 11/2021
2	Overweight 12/2021 - 02/2011
2	Brain Stem Neoplasms (Brain Stem Tumor) 01/2020 - 04/2008
2	Hypertension (High Blood Pressure) 03/2016 - 11/2010
2	Obesity 03/2016 - 02/2011
2	Deafness (Deaf Mutism) 11/2015 - 06/2014

Drug/Important Bio-Agent (IBA)

15	dipinacoline glutamateIBA 01/2023 - 10/2011
10	Cisplatin (Platino)FDA LinkGeneric 04/2015 - 09/2006
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2009
8	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 09/2006
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2004
8	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 07/2002
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 09/2006
7	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 12/2003
7	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2002
7	Topotecan (Hycamtin)FDA LinkGeneric 01/2019 - 01/2002
6	Bevacizumab (Avastin)FDA Link 01/2024 - 11/2012
6	Phosphotransferases (Kinase)IBA 01/2022 - 01/2009
6	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2009
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2020 - 03/2007
5	Alkylating AgentsIBA 10/2023 - 03/2005
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2010
5	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2010
5	ErbB Receptors (EGF Receptor)IBA 10/2019 - 09/2010
4	Growth Hormone (Somatotropin)IBA 01/2023 - 02/2011
4	Tyrosine Kinase InhibitorsIBA 10/2022 - 09/2013
4	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 04/2003
4	Dasatinib (BMS 354825)FDA Link 12/2021 - 06/2013
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016 - 11/2012
3	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 01/2015
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2022 - 03/2006
3	CrizotinibIBA 12/2021 - 01/2018
3	OSI-420IBA 02/2020 - 01/2009
3	ChromatinIBA 01/2019 - 08/2012
3	HhAntag691IBA 09/2017 - 11/2013
3	Lapatinib (GW572016)FDA Link 05/2015 - 09/2010
3	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2014 - 11/2010
3	Amifostine (Ethyol)FDA LinkGeneric 06/2014 - 08/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 11/2012
3	vandetanib (ZD6474)IBA 09/2013 - 11/2010
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2013 - 11/2010
3	EnzymesIBA 01/2009 - 07/2002
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2009 - 07/2002
2	Vorinostat FDA Link 01/2024 - 01/2022
2	7-hydroxymethotrexateIBA 12/2023 - 01/2016
2	PlatinumIBA 10/2023 - 11/2015
2	Dihydrotachysterol (AT 10)IBA 01/2023 - 03/2013
2	MLN 8237IBA 01/2023 - 06/2015
2	Cell-Free Nucleic AcidsIBA 01/2022 - 11/2021
2	crenolanibIBA 01/2022 - 01/2021
2	ORALIT (ORS)IBA 01/2022 - 12/2019
2	Isotretinoin (Accutane)FDA LinkGeneric 09/2021 - 10/2018
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2021 - 01/2018
2	ElectrolytesIBA 01/2021 - 09/2006
2	VemurafenibIBA 05/2020 - 04/2014
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 12/2019 - 03/2016
2	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2019 - 02/2011
2	Fluorouracil (Carac)FDA LinkGeneric 12/2015 - 09/2011
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 08/2015 - 09/2011
2	3- (4- ((4- chlorophenyl)sulfonyl)- 4- (2,5- difluorophenyl)cyclohexyl)propanoic acidIBA 08/2015 - 09/2011

Therapy/Procedure

81	Therapeutics 04/2024 - 01/2002
65	Radiotherapy 10/2023 - 01/2004
55	Drug Therapy (Chemotherapy) 10/2023 - 01/2002
25	Craniospinal Irradiation 10/2023 - 08/2002
14	Aftercare (After-Treatment) 01/2023 - 08/2002
8	Adjuvant Chemotherapy 01/2017 - 07/2006
4	Ventriculoperitoneal Shunt 05/2018 - 10/2005
4	Hearing Aids (Hearing Aid) 11/2015 - 08/2008
4	Cranial Irradiation 06/2010 - 08/2002
2	Molecular Targeted Therapy 01/2017 - 04/2006